Human Reproduction Update Advance Access originally published online on May 3, 2006
Human Reproduction Update 2006 12(5):557-571; doi:10.1093/humupd/dml020
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ovarian feedback, mechanism of action and possible clinical implications
Department of Obstetrics and Gynaecology, University of Thessalia, Medical School, 22 Papakiriazi Street, 41222 Larissa, Greece
To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, University of Thessalia, Medical School, 22 Papakiriazi Street, 41222 Larissa, Greece. E-mail: messinis{at}med.uth.gr
The secretion of gonadotrophins from the pituitary in women is under ovarian control via negative and positive feedback mechanisms. Steroidal and non-steroidal substances mediate the ovarian effects on the hypothalamic-pituitary system. During the follicular phase of the cycle, estradiol (E2) plays a key role, while circulating progesterone (at low concentrations) and inhibin B contribute to the control of LH and FSH secretion respectively. During the luteal phase, both E2 and progesterone regulate secretion of the two gonadotrophins, while inhibin A plays a role in FSH secretion. The intercycle rise of FSH is related to changes in the levels of the steroidal and non-steroidal substances during the luteal-follicular transition. In terms of the positive feedback mechanism, E2 is the main component sensitizing the pituitary to GnRH. Activity of a non-steroidal ovarian substance, named gonadotrophin surge-attenuating factor (GnSAF), has been detected after ovarian stimulation. It is hypothesized that GnSAF, by antagonizing the sensitizing effect of E2 on the pituitary, regulates the amplitude of the endogenous LH surge at midcycle. Disturbances in the feedback mechanisms can occur in various abnormal conditions or after treatment with pharmaceutical compounds that interfere with the production or the action of endogenous hormones.
Key words: FSH / LH / estrogen / ovarian feedback / progesterone
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  V. Michopoulos, S. L. Berga, J. R. Kaplan, and M. E. Wilson Social Subordination and Polymorphisms in the Gene Encoding the Serotonin Transporter Enhance Estradiol Inhibition of Luteinizing Hormone Secretion in Female Rhesus Monkeys Biol Reprod, December 1, 2009; 81(6): 1154 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gordon, R. Aguilar, J. C. Garrido-Gracia, S. Guil-Luna, R. Sanchez-Cespedes, Y. Millan, J. Martin de las Mulas, and J. E. Sanchez-Criado Activation of estrogen receptor-{alpha} induces gonadotroph progesterone receptor expression and action differently in young and middle-aged ovariectomized rats Hum. Reprod., October 1, 2009; 24(10): 2618 - 2628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lamba, J. Fortin, S. Tran, Y. Wang, and D. J. Bernard A Novel Role for the Forkhead Transcription Factor FOXL2 in Activin A-Regulated Follicle-Stimulating Hormone {beta} Subunit Transcription Mol. Endocrinol., July 1, 2009; 23(7): 1001 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gordon, J. C Garrido-Gracia, R. Aguilar, S. Guil-Luna, Y. Millan, J. M. de las Mulas, and J. E Sanchez-Criado Ovarian stimulation with FSH reduces phosphorylation of gonadotrope progesterone receptor and LH secretion in the rat Reproduction, January 1, 2009; 137(1): 151 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Weinbauer, M. Niehoff, M. Niehaus, S. Srivastav, A. Fuchs, E. Van Esch, and J. M. Cline Physiology and Endocrinology of the Ovarian Cycle in Macaques Toxicol Pathol, December 1, 2008; 36(7_suppl): 7S - 23S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Buse, M. Zoller, and E. Van Esch The Macaque Ovary, with Special Reference to the Cynomolgus Macaque (Macaca fascicularis) Toxicol Pathol, December 1, 2008; 36(7_suppl): 24S - 66S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Andreu-Vieyra, R. Chen, and M. M. Matzuk Effects of Granulosa Cell-Specific Deletion of Rb in Inha-{alpha} Null Female Mice Endocrinology, August 1, 2007; 148(8): 3837 - 3849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.M. Fatemi, C. Bourgain, P. Donoso, C. Blockeel, E.G. Papanikolaou, B. Popovic-Todorovic, and P. Devroey Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept Hum. Reprod., May 1, 2007; 22(5): 1260 - 1263. [Abstract] [Full Text] [PDF]
|
|